KJ Mather, T Funahashi, Y Matsuzawa, S … - Diabetes, 2008 - Am Diabetes Assoc RESULTS— Baseline adiponectin was a strong independent predictor of incident
diabetes in all treatment groups (hazard ratio per ∼3 μg/ml higher level;
0.61 in the lifestyle, 0.76 in the metformin, and the 0.79 in placebo ... Cited by 23 - Related articles - BL Direct - All 5 versions
- ►nih.gov JP Crandall, WC Knowler, SE Kahn, D Marrero …, 2008 - nature.com David Marrero, PhD is the JO Ritchey Professor of Medicine at Indiana
University, Indianapolis, IN, USA. Dr Marrero is an expert in the field of
clinical trials in diabetes and translation research, which moves ... Cited by 13 - Related articles - All 4 versions
H Mochari, A Ferris, S Adigopula, G Henry, L … - Preventive Cardiology, 2007 - interscience.wiley.com Lack of knowledge and awareness of cardiovascular disease may contribute to
disproportionately higher risk in minorities. The authors studied minorities in
Harlem, New York (N=214), to evaluate knowledge and preventive behaviors. ... Cited by 7 - Related articles - BL Direct - All 3 versions
- ►clinicalcornerstone.com [PDF] VA Fonseca - Clinical cornerstone, 2008 - Elsevier Overt type 2 diabetes is usually preceded by a condition known as prediabetes,
which is characterized by impaired fasting glucose (IFG) and impaired glucose
tolerance (IGT). Both IFG and IGT exhibit elevated glucose levels that are ... Cited by 5 - Related articles - All 5 versions
[CITATION] Barriers to treatment adherence for pediatric patients with sickle cell disease and their …
AC Modi, LE Crosby, SM Guilfoyle, KL … - Childrenʼs Health Care, 2009 - Routledge Cited by 5 - Related articles
DM Mann, D Ponieman, H Leventhal, EA … - Journal of Behavioral Medicine, 2009 - Springer Abstract Despite the effectiveness of drug therapy in diabetes management high
rates of poor adherence persist. The purpose of this study was to identify
potentially modifiable patient disease and medication beliefs associ- ated ... Cited by 7 - Related articles - All 2 versions
W McLean, F PharmD - CANADIAN PHARMACISTS JOURNAL, 2007 - cpjournal.ca Nonadherence, formerly called “noncompliance,” continues unabated with no
evidence that there have been any significant improvements in the general
population. Although various reduction efforts have been studied, ... Cited by 1 - Related articles - BL Direct - All 4 versions
K Treadaway, G Cutter, A Salter, S Lynch, J … - Journal of Neurology, 2009 - Springer EM Frohman, MD, PhD ( ) · K. Treadaway, LCSW · A. Salter, MPH · O. Stüve,
MD, PhD Dept. of Neurology University of Texas Southwestern Medical Center at
Dallas 5323 Harry Hines Boulevard Dallas, TX 75235, USA Tel.: 214-645-0555 ... Cited by 1 - Related articles - All 2 versions
BJ Zarowitz - Geriatric Nursing, 2007 - Elsevier The National Council on Patient Information and Education has aptly termed
medication nonadherence “America's Other Drug Problem.” 1 Elderly persons
have been shown to be at a greater risk of medication nonadherence than the ... Cited by 1 - Related articles - All 4 versions
